Rapid Changes in Cardiac Myofilament Function following the Acute Activation of Estrogen Receptor-Alpha
Open Access
- 30 July 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (7), e41076
- https://doi.org/10.1371/journal.pone.0041076
Abstract
Estrogens have well-recognized and complex cardiovascular effects, including altering myocardial contractility through changes in myofilament function. The presence of multiple estrogen receptor (ER) isoforms in the heart may explain some discrepant findings about the cardiac effects of estrogens. Most studies examining the impact of estrogens on the heart have focused on chronic changes in estrogen levels, and have not investigated rapid, non-genomic pathways. The first objective of this study was to determine how acute activation of ERα impacts cardiac myofilaments. Nongenomic myocardial estrogen signaling is associated with the activation of a variety of signaling pathways. p38 MAPK has been implicated in acute ER signaling in the heart, and is known to affect myofilament function. Thus, the second objective of this study was to determine if acute ERα activation mediates its myofilament effects through p38 MAPK recruitment. Hearts from female C57Bl/6 mice were perfused with the ERα agonist PPT and myofilaments isolated. Activation of ERα depressed actomyosin MgATPase activity and decreased myofilament calcium sensitivity. Inhibition of p38 MAPK attenuated the myofilament effects of ERα activation. ERα stimulation did not affect global myofilament protein phosphorylation, but troponin I phosphorylation at the putative PKA phosphorylation sites was decreased. Changes in myofilament activation did not translate into alterations in whole heart function. The present study provides evidence supporting rapid, non-genomic changes in cardiac myofilament function following acute ERα stimulation mediated by the p38 MAPK pathway.Keywords
This publication has 32 references indexed in Scilit:
- Aromatase Deficiency Confers Paradoxical Postischemic CardioprotectionEndocrinology, 2011
- Some precautions in using chelators to buffer metals in biological solutionsCell Calcium, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJama-Journal Of The American Medical Association, 2004
- Cardioprotection through a PKC-dependent decrease in myofilament ATPaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseThe New England Journal of Medicine, 2003
- Estrogen supplement prevents the calcium hypersensitivity of cardiac myofilaments in ovariectomized ratsLife Sciences, 2000
- Effect of 17β‐oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea‐pig isolated cardiac myocytesBritish Journal of Pharmacology, 1992
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Effects of gonadectomy and hormonal replacement on rat hearts.Circulation Research, 1987
- The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats.Circulation Research, 1984